Reduced apM1 Levels in Type 2 Diabetes
Author Information
Author(s): MICHAEL A. STATNICK, LISA S. BEAVERS, LAURA J. CONNER, HELENA COROMINOLA, DWAYNE JOHNSON, CRAIG D. HAMMOND, RONIT RAFAELOFF-PHAIL, THOMAS SENG, TODD M. SUTER, JAMES P. SLUKA, ERIC RAVUSSIN, ROBERT A. GADSKI, JOSE F. CARO
Primary Institution: Lilly Research Laboratories
Hypothesis
The study aims to identify differentially expressed genes in omental adipose tissue of human patients with Type 2 diabetes.
Conclusion
The study found that apM1 mRNA levels are significantly reduced in the omental and subcutaneous adipose tissue of patients with Type 2 diabetes.
Supporting Evidence
- apM1 mRNA levels were significantly reduced in omental adipose tissue of obese Type 2 diabetic patients compared to lean and obese normoglycemic subjects.
- apM1 was expressed in mature human adipocytes but not in preadipocytes.
- Expression of apM1 was reduced approximately 2.2-2.5 fold in omental adipose tissue from Type 2 diabetic patients compared to lean or obese non-diabetic individuals.
Takeaway
This study shows that a protein called apM1 is lower in the fat of people with Type 2 diabetes, which might be important for understanding diabetes.
Methodology
The study used a subtracted cDNA library and RT-PCR to analyze apM1 expression in adipose tissue from patients.
Potential Biases
The small number of patients and gender-specific variability in apM1 levels may introduce bias.
Limitations
The study had a small sample size and focused only on female patients, which may limit the generalizability of the findings.
Participant Demographics
Patients included lean non-diabetic, obese non-diabetic, and obese Type 2 diabetic individuals, primarily female.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website